Subscribe to Updates in Legal, Economic & Regulatory Affairs

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Expert Analyses of the following article:

Follow-On Biologics Legislation Could Save Billions of Dollars, According to CBO

Source: www.kaisernetwork.org
Jeff StierJuly 1, 2008
CBO Data On Follow-on Biologics Is More Interesting Than It Sounds.
Author: Jeff Stier, Associate Director, American Council on Science and Health
The report explains that creating a pathway to allow for follow-on biologics will save billions of dollars over the next 10 years. The report will be used to press for quick passage of the House and Senate versions of the legislation.
July 1, 2008
CBO Estimates About Savings From Follow-On Biologics Are (Necessarily) Very Crude -- and Probably Overly Optimistic
Author: GLG Expert Contributor
There any many imponderables in the CBO estimates, including the period of marketing exclusivity (if any) granted by not-yet-passed legislation and the extent to which the FDA requires new clinical trials for follow-on biologics.  I would argue, therefore, that their predictions are premature.

More GLG News in
Legal, Economic & Regulatory Affairs

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-09-06T21:45:17.077